Association Between Serum Fibroblast Growth Factor 21 and Mortality Among Patients With Coronary Artery Disease | Zendy

Qing Li | Zendy; Yuan Zhang | Zendy; Ding Ding | Zendy; Yunou Yang | Zendy; Qian Chen | Zendy; Dongfang Su | Zendy; Xuechen Chen | Zendy; Wenqi Yang | Zendy; Jian Qiu | Zendy; Wenhua Ling | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association Between Serum Fibroblast Growth Factor 21 and Mortality Among Patients With Coronary Artery Disease

Author(s) -

Qing Li,

Yuan Zhang,

Ding Ding,

Yunou Yang,

Qian Chen,

Dongfang Su,

Xuechen Chen,

Wenqi Yang,

Jian Qiu,

Wenhua Ling

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-2308

Subject(s) - medicine , fgf21 , quartile , coronary artery disease , body mass index , confidence interval , proportional hazards model , prospective cohort study , waist , risk factor , relative risk , fibroblast growth factor , receptor

Epidemiological studies have shown that serum fibroblast growth factor 21 (FGF21) levels were elevated in obesity and its related metabolic disorders. This prospective study assessed whether there was an independent association of serum FGF21 levels with all-cause and cardiovascular disease (CVD) mortality among patients with coronary artery disease (CAD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research